ESC 365 - Colchicine in patients with coronary disease undergoing coronary artery bypass surgery: a meta-analysis of randomized controlled trials

ESC Premium Access

Colchicine in patients with coronary disease undergoing coronary artery bypass surgery: a meta-analysis of randomized controlled trials

Session: Risk stratification and treatment in patients undergoing CABG

Topic: Pharmacotherapy

Speaker: Doctor H. Kirov (Jena, DE)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Doctor Hristo Kirov

University hospital Jena, Jena (Germany)

0 follower

4 more presentations in this session

Clinical impact of Sarcopenia on long-term mortality in patients undergoing coronary bypass grafting

Speaker: Doctor J. Jo (Seoul, KR)

The impact of type 2 diabetes on short term myocardial morphological, functional, and energetic recovery post coronary artery bypass surgery in patients with ischemic heart disease

Speaker: Doctor S. Kotha (Leeds, GB)

The utility of angiography-derived fractional flow reserve in predicting graft occlusions prior to bypass surgery

Speaker: Doctor M. Buske (Leipzig, DE)

A randomized controlled trial of an eight-week cardiac rehabilitation home verse hospital exercise programme for post coronary cardiac bypass patients

Speaker: Doctor M. Takroni (Riyadh, SA)

Access the full session

Risk stratification and treatment in patients undergoing CABG

Speakers: Doctor H. Kirov, Doctor J. Jo, Doctor S. Kotha, Doctor M. Buske, Doctor M. Takroni

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources